Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

US-China tech dynamics shine light on thriving underwater drone investments, notes GlobalData

In a race to strengthen underwater capabilities, the US and China are accelerating efforts in advanced technologies such as the Manta Ray underwater drone, highlighting their strategic significance. The recent developments highlight the critical role of underwater drones in military, environmental, and infrastructure applications. With significant investments driving innovation in endurance, navigation, and data collection […]
Read more

Diagnosed prevalent cases of chronic kidney disease to reach 22.97 million across 7MM in 2033, predicts GlobalData

The diagnosed prevalent cases of chronic kidney disease (CKD) across the seven major markets (*7MM) are projected to increase at an annual growth rate (AGR) of 0.90% from 21.08 million in 2023 to 22.97 million in 2033, forecasts GlobalData, a leading data and analytics company. GlobalData’s latest report, “Chronic Kidney Disease: Epidemiology Forecast to 2033,” […]
Read more

Synergistic safety profile could increase sublingual apomorphine competitiveness, says GlobalData

Sublingual apomorphine (SL-APO) is a dopamine agonist (DA) marketed by Bial under the brand name Kynmobi in several countries for the on-demand treatment of levodopa wear-off (OFF-episodes) that are not sufficiently controlled by levodopa “add-on” (adjunct) therapies. At the 10th Congress of the European Academy of Neurology (EAN) 2024, Dr. Diego Santos García presented a […]
Read more

Cross-border real-time payments make tangible progress as over 50% consumers use them, says GlobalData

Cross-border payments are becoming increasingly important to international economies. Around 63% of global consumers use international real-time payments (RTPs) services to send money to family and friends and 51% use them only to pay for goods and services, according to the 2024 Financial Services Consumer Survey* conducted by GlobalData, a leading data and analytics company. […]
Read more

Opicapone demonstrates efficacy in real-world clinical practice, says GlobalData

Opicapone is a catechol-O-methyltransferase (COMT) inhibitor marketed in several countries by either Amneal Pharmaceuticals or Bial, depending on region, under the brand name “Ongentys” for the treatment of levodopa wear-off in Parkinson’s disease (PD). At the 10th Congress of the European Academy of Neurology (EAN) 2024, Dr. Maria-Rosario Luquin and Dr. Lydia López Manzanares separately […]
Read more

South Korea radiosurgery systems market to see 6% CAGR through 2033, forecasts GlobalData

Brain tumors and associated neurological disorders pose a serious medical issue, impacting millions of people worldwide. These tumors interfere with normal brain activity, resulting in a range of symptoms such as headaches, seizures, and cognitive decline. This has driven the demand for advanced, minimally invasive treatments. In this context, South Korea’s radiosurgery systems market is […]
Read more

GenAI to revolutionize financial services with enhanced decision-making and personalization, says GlobalData

Generative AI (genAI) is set to transform financial services across banking, insurance, and wealth management. This technology is advancing through distinct phases, offering transformative capabilities such as enhanced decision-making, personalized services, and innovative product development. With significant funding growth and increasing adoption, genAI is set to drive unprecedented innovation and operational efficiency in the industry, […]
Read more

Prioritized investments from pharma companies shaping competitive pipeline landscape of bronchiectasis, says GlobalData

Recent studies have allowed the unexplored field of bronchiectasis to be further investigated by shedding light on the mechanisms behind the disease’s pathophysiology. In recent years, bronchiectasis has garnered a significant amount of attention, with pharmaceutical companies prioritizing their investments in the development of promising pipeline agents to treat the disease through various mechanisms of […]
Read more

AI and robotics unlock sustainable efficiency in oil and gas sector, says GlobalData

Artificial intelligence (AI) and robotics are leading the transformative changes in the oil and gas sector, accelerating advancements in operational efficiency, safety, and environmental sustainability. These technologies are reshaping how the sector approaches exploration, production, refining, and logistics, instituting a new era of innovations for heightened productivity, efficiency, sustainability, and safety, according to GlobalData, a […]
Read more

Safinamide outperforms rasagiline in efficacy, cost-efficacy, and forecasted sales, says GlobalData

Safinamide is a monoamine oxidase B (MAO-B) inhibitor marketed in several countries under the brand name Xadago by Newron Pharmaceuticals for the treatment of levodopa wear-off in Parkinson’s disease (PD). At the 10th Congress of the European Academy of Neurology (EAN) 2024, Dr. Ester Morales García presented a pharmacoeconomic report comparing safinamide to its competitor […]
Read more

Ajovy benefits diminish with migraine treatment cessation and re-initiation, says GlobalData

The interim results from the observational, prospective Phase IV Pan-European Real-Life (PEARL) study, presented at the 10th Congress of the European Academy of Neurology, indicate that treatment cessation and re-initiation can reduce the benefits of Teva Pharmaceutical’s Ajovy for migraine management. Continuous administration of Ajovy is crucial for effective prevention, challenging current guidelines that recommend […]
Read more

Healey platform data to pave phase III path for Prilenia’s pridopidine, says GlobalData

Developing disease-modifying treatments for amyotrophic lateral sclerosis (ALS), a rare and aggressive disease, has proven challenging. The high failure rate in ALS clinical trials is often attributed to the disease’s unclear etiology and complex pathophysiology. At the 10th Congress of the European Academy of Neurology (EAN) 2024, Prilenia Therapeutics presented promising results from the additional […]
Read more

Preventative treatment of chronic migraine will continue to evolve in short-term with anti-CGRP mAbs effectiveness, says GlobalData

OnabotulinumtoxinA (BoNT-A) and monoclonal antibodies against the calcitonin gene-related protein (anti-CGRP mAbs) have emerged as the first disease-specific preventative treatments to be approved for chronic migraine. At the 10th Congress of the European Academy of Neurology (EAN) 2024, Danilo Antonio Montisano, MD, presented real-world evidence findings from a retrospective, observational multicenter cohort study (RAMO) comparing […]
Read more
1 … 126 127 128 129 130 … 776